01 March 2004
Effects of poly(ADP-ribose) polymerase inhibition on inflammatory cell migration in a murine model of asthma
László Virág, Peter Bai, István Bak, Pal Pacher, Jon Mabley, Lucas Liaudet, Edina Bakondi, Pal Gergely, Mark Kollai, Csaba SzaboMed Sci Monit 2004; 10(3): BR77-83 :: ID: 11613
Abstract
Background:Poly(ADP-ribose) polymerase-1 (PARP-1), a monomeric nuclear enzyme present in eukaryotes, plays a role in cell death, inflammatory mediator expression, and mononuclear cell recruitment in various experimental models of inflammation and reperfusion injury. Part of the molecular mechanism of this function involves the regulation of cytokine and chemokine production. Since chemokines are principal regulators of mononuclear and polymorphonuclear cell trafficking in asthma, we investigated the possibility whether PARP modulates chemokine production and cell recruitment in a murine model of asthma.Material/Methods: We studied ovalbumin-sensitized mice challenged with a single dose of ovalbumin.Results: PARP inhibition with the phenanthridinone-based PARP inhibitor PJ34 suppressed inflammatory cell migration. These effects were associated with downregulation of the CC chemokine MIP-1alpha, but not the CXC chemokine MIP-2. The production of TNF- alpha and IL-12, but not IL-5 or IL-13, was also suppressed by PARP inhibition.Conclusions: Our results demonstrate the pathogenetic role of PARP activation in a murine model of asthma. PARP selectively regulates the production of certain chemokines and cytokines in this experimental model, which may be responsible for some of the observed protective effects seen in the current murine asthma model.
Keywords: Asthma - drug therapy, Bronchoalveolar Lavage, Catalysis, Cell Death, Chemokines - metabolism, Cytokines - metabolism, Enzyme Inhibitors - pharmacology, Interleukin-10 - metabolism, Interleukin-12 - metabolism, Interleukin-13 - metabolism, Interleukin-5 - metabolism, Leukocytes, Mononuclear - metabolism, Lung - pathology, Ovalbumin - metabolism, Ovalbumin - pharmacology, Peroxidase - metabolism, Poly(ADP-ribose) Polymerases - antagonists & inhibitors, Time Factors, Tumor Necrosis Factor-alpha - metabolism, Asthma - drug therapy, Bronchoalveolar Lavage, Catalysis, Cell Death, Chemokine CXCL2, Chemokines - metabolism, Cytokines - metabolism, Enzyme Inhibitors - pharmacology, Interleukin-10 - metabolism, Interleukin-12 - metabolism, Interleukin-13 - metabolism, Interleukin-5 - metabolism, Leukocytes, Mononuclear - metabolism, Lung - pathology, Ovalbumin - pharmacology, Peroxidase - metabolism, Poly(ADP-ribose) Polymerases - antagonists & inhibitors, Time Factors, Tumor Necrosis Factor-alpha - metabolism
Editorial
01 April 2025 : Editorial
Editorial: Rapid Testing for the Avian Influenza A(H5N1) Virus is Urgently Required as Infections in Poultry and Dairy Cows are on the Rise, and so is Transmission to HumansDOI: 10.12659/MSM.949109
Med Sci Monit 2025; 31:e949109
In Press
Review article
A Review of Circulating Tumor DNA (ctDNA) and the Liquid Biopsy in Cancer Diagnosis, Screening, and Monitor...Med Sci Monit In Press; DOI: 10.12659/MSM.949300
Clinical Research
Buccal Acupuncture Reduces the Dose of Sufentanil Needed in Laparoscopic Gynecological SurgeryMed Sci Monit In Press; DOI: 10.12659/MSM.947088
Review article
Global Guidelines and Trends in HPV Vaccination for Cervical Cancer PreventionMed Sci Monit In Press; DOI: 10.12659/MSM.947173
Clinical Research
Serum Prolidase and Ischemia-Modified Albumin Levels in Neural Tube Defects: A Comparative Study of Myelome...Med Sci Monit In Press; DOI: 10.12659/MSM.947873
Most Viewed Current Articles
17 Jan 2024 : Review article 7,932,897
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 702,919
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 29,882
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 23,844
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912